Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY

v3.20.2
CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
Total
Common Stock
Additional Paid-In Capital
Treasury Stock
Accumulated Deficit
Beginning balance at Apr. 30, 2018 $ 33,733,591 $ 18,334 $ 66,557,005 $ (70,000) $ (32,771,748)
Beginning balance (in shares) at Apr. 30, 2018   18,333,521      
Stock-based compensation 1,190,385   1,190,385    
Common stock issued for cashless stock options exercised 0 $ 112 (112)    
Common stock issued for cashless stock options exercised (in shares)   111,666      
Common stock issued for stock options exercised for cash $ 128,201 $ 56 128,145    
Common stock issued for stock options exercised for cash (in shares) 194,276 56,910      
Common stock issued for cashless warrant exercise $ 0 $ 120 (120)    
Common stock issued for cashless exercise of stock options (in shares) 111,666 119,594      
Common stock issued for warrants exercised for cash $ 100,000 $ 44 99,956    
Common stock issued for warrants exercised for cash (in shares)   43,860      
Warrants issued with debt financing 615,587   615,587    
Amortization of warrant based cost issued for services 1,713   1,713    
Purchase of treasury stock, net of broker fees (7,370,000)     (7,370,000)  
Re-sale of treasury stock, net of broker fees 7,370,000     7,370,000  
Issuance costs (29,832)   (29,832)    
Net loss (9,278,217)       (9,278,217)
Ending balance at Apr. 30, 2019 26,461,428 $ 18,666 68,562,727 (70,000) (42,049,965)
Ending balance (in shares) at Apr. 30, 2019   18,665,551      
Stock-based compensation 2,116,309   2,116,309    
Amortization of restricted stock issued for service 122,250   122,250    
Common stock issued for cashless stock options exercised 0 $ 191 (191)    
Common stock issued for cashless stock options exercised (in shares)   190,559      
Common stock issued for stock options exercised for cash $ 962,650 $ 278 962,372    
Common stock issued for stock options exercised for cash (in shares) 363,334 277,678      
Common stock issued for cashless warrant exercise $ 0 $ 77 (77)    
Common stock issued for cashless exercise of stock options (in shares) 190,559 76,929      
Amortization of warrant based cost issued for services $ 36,719   36,719    
Restricted stock issued for services, subject to vesting 0 $ 144 (144)    
Restricted stock issued for services, subject to vesting (in shares)   144,803      
Common stock issued for equity raise, net of underwriter costs of $1,222,371 16,044,879 $ 2,415 16,042,464    
Common stock issued in equity raise, net of underwriter costs of $1,222,371 (in shares)   2,415,000      
Issuance costs (51,282)   (51,282)    
Beneficial conversion feature on Convertible Debt 1,692,309   1,692,309    
Common stock short swing reclamation 21,760   21,760    
Net loss (5,659,065)       (5,659,065)
Ending balance at Apr. 30, 2020 $ 41,747,957 $ 21,771 $ 89,505,216 $ (70,000) $ (47,709,030)
Ending balance (in shares) at Apr. 30, 2020   21,770,520